NAPIGEN, Inc., a biotechnology company specializing in advanced gene-editing technologies, has received notification from the ...
ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced its adoptive cell therapy, ELIAS Cancer Immunotherapy (ECI®), has received full approval from the U.S.
I’ve been around food safety for nearly 50 years in government, academia, and the private sector. I’ve seen a lot of progress to make ...